At the completion of this activity, the participant will be able to:
1. Explain the differences in spectrum for our newer beta-lactam beta-lactamase inhibitor combinations
2. Choose the preferred regimen for patients with Stenotrophomonas maltophillia infections
3. Select the preferred regimen for patients with ESBL enterobacterales infections
4. Recommend the preferred regimen for patients with Carbapenem resistant enterobacterales infections

Session date: 
10/19/2026 - 12:00pm to 1:00pm EDT
Location: 
AGH Kent Room (2nd Floor Magovern Conference Center)
To Join Zoom Webinar:
https://highmarkhealth.zoom.us/j/98672570454?pwd=VU80YWJYNjgraGVsQ0xkU2xSNWozQT09
Meeting ID: 986 7257 0454; Passcode: 877628
United States
See map: Google Maps
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Contact Hours
Please login or register to take this course.